We use cookies for a better user experience. Read our Privacy Policy
I Agree
Aptamer Market Outlook, 2017-2025
The corporate survey study by the Transparency Market Research projects that the global aptamer market will showcase a brilliant growth rate of 20 % during the forecast period for the study, i.e. 2017 to 2025. It also predicts that the global aptamer market will expand from its initial evaluation to surpass the value of US$ 5 billion at the end of the forecast period. Some of the major drivers for the development in the global aptamer market include constant advancements in the technologies intended for selection of proper aptamer as well as the rising focus by several industry players on research and development.
Furthermore, benefits and features provided by the solutions in the global aptamer market such as cost effectiveness as well as high thermal stability are anticipated to fast track the adoption of the products within the industry. On the other hand, dearth of regulatory guidelines pertaining to development of molecules as well as the negative side effects of using aptamers may restrict the growth within the global aptamer market in coming years. However, constant efforts on development of novel aptamers intended for usage in a number of medical applications is bound to foster the development in the global aptamer market in coming years. The segments in the global aptamer market based on the material are peptide aptamer as well as nucleic acid aptamer.
Segments in the global aptamer market by the technique used are MARAS and SELEX techniques, among others. Based by the technique of selection, the SELEX technique is expected to dominate the global aptamer market over the forecast period. This trend can be attributed to the rising focus on advancing the SELEX technique by diversification into novel techniques such as M-SELEX as well as CE-SELEX.
Some of the key applications for the products and solutions provided by the manufacturers and players within the global aptamer market include diagnostics, research, and therapeutics, among others. The segment of research dominated the application segments in the global aptamer market in recent past and is also expected to remain dominant in the global aptamer market throughout the forecast years. This trend can be attributed to the rising investments by players in the global aptamer market intended for research and development. The diagnostics segment also accounted for a high share in the global aptamer market, owing to medical advancements such as effective ADME or adsorption, distribution, metabolism, and excretion properties.
Major regions and leading economies assessed thoroughly in the business intelligence study on the global aptamer market include Europe (including Germany, Italy, the United Kingdom, France, Spain, and rest of the Europe), Latin America (including Brazil, Mexico, and rest of the Latin America), North America (including the United States and Canada), Asia Pacific (including Japan, Australia and New Zealand, China, India, and rest of the Asia Pacific), Middle East and Africa (including the Gulf Cooperation Council countries, South Africa, and rest of the Middle East and Africa), and rest of the World. Among these, the North America region led the global aptamer market in recent past, owing to rising investments from various regional players.
Few of the most prominent players covered within the business intelligence report on the global aptamer market include Aptagen, LLC, Aptamer Sciences, Inc., CD Genomics, NAXXON Pharma, TriLink BioTechnologies, LLC, Pfizer, Inc., AM Biotech, Aptamer Group, Base Pair Biotechnologies, NeoVentures Biotechnology, Inc., and Aptus Biotech, among others. Players in the global aptamer market are heavily investing in research and development activities in order to diversify the scope of applications for the aptamer molecules. Furthermore, several companies operating within the global aptamer market are also engaged in corporate advancement moves such as mergers and acquisitions.
The global aptamer market has been segmented as follows:
|
Material |
|
|
Technique
|
|
|
Application |
|
|
Geography |
|
The global aptamer market was valued at approximately US$ 1.0 Bn in 2016 and is anticipated to reach at a US$ 5.0 Billion By 2025
Aptamer Market is anticipated to grow at a CAGR of 20.9% during the forecast period
North America accounted for a major share of the global Aptamer Market
Drivers for the development in the global aptamer market include constant advancements in the technologies intended for selection of proper aptamer as well as the rising focus by several industry players on research and development.
Key players in the global Aptamer Market include Aptagen, LLC, Aptamer Sciences, Inc., CD Genomics, NAXXON Pharma, TriLink BioTechnologies, LLC, Pfizer, Inc., AM Biotech, Aptamer Group, Base Pair Biotechnologies, NeoVentures Biotechnology, Inc., and Aptus Biotech
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2. Assumptions and Research Methodology
Chapter 3. Executive Summary : Global Aptamer Market
Chapter 4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.1.2. Industry Evolution / Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Pipeline Analysis – Aptamer Market
4.4. Porter’s Five Force Representation
4.5. Global Aptamer Market Analysis and Forecasts, 2015-2025
4.5.1. Market Revenue Projection (US$ Mn)
4.5.2. Market Outlook
4.6. Key Trends
Chapter 5. Global Aptamer Market Analysis and Forecasts, By Material Type
5.1. Key Findings / Developments
5.2. Introduction & Definition
5.3. Market Value Forecast By Material Type, 2016–2025
5.3.1. Nucleic acid Aptamer
5.3.2. Peptide Aptamer
5.4. Market Attractiveness By Material Type
Chapter 6. Global Aptamer Market Analysis and Forecasts, By Selection Technique
6.1. Key Findings / Developments
6.2. Introduction & Definition
6.3. Market Value and Volume Forecast By Selection Technique, 2016–2025
6.3.1. SELEX Technique
6.3.2. Others
6.4. Market Attractiveness By Selection Technique
Chapter 7. Global Aptamer Market Analysis and Forecasts, By Application
7.1. Key Findings / Developments
7.2. Introduction & Definition
7.3. Market Value and Volume Forecast By Application, 2017–2025
7.3.1. Research
7.3.2. Diagnostics
7.3.3. Therapeutics
7.3.4. Others
7.4. Market Attractiveness By Application
Chapter 8. Global Aptamer Market Analysis and Forecasts, By Geography/Region
8.1. Geographical Representation
8.2. Market Value and Volume Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Rest of World
8.3. Market Attractiveness By Region
8.4. Key Trends
Chapter 9. North America Aptamer Market Analysis and Forecast
9.1. Market Value Forecast By Country , 2017–2025
9.1.1. U.S.
9.1.2. Canada
9.2. Market Value Forecast By Material Type, 2016–2025
9.3. Market Value Forecast By Selection Technique, 2016–2025
9.4. Market Value Forecast By Application, 2016-2025
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Material Type
9.5.3. By Selection Technique
9.5.4. By Application
9.6. Key Trends
Chapter 10. Europe Aptamer Market Analysis and Forecast
10.1. Market Value Forecast By Country , 2017–2025
10.1.1. Germany
10.1.2. France
10.1.3. U.K.
10.1.4. Spain
10.1.5. Italy
10.1.6. Rest of Europe
10.2. Market Value Forecast By Material Type, 2016–2025
10.3. Market Value Forecast By Selection Technique, 2016–2025
10.4. Market Value Forecast By Application, 2016-2025
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Material Type
10.5.3. By Selection Technique
10.5.4. By Application
10.6. Key Trends
Chapter 11. Asia Pacific Aptamer Market Analysis and Forecast
11.1. Market Value Forecast By Country , 2017–2025
11.1.1. China
11.1.2. Japan
11.1.3. India
11.1.4. Australia & New Zealand
11.1.5. Rest of APAC
11.2. Market Value Forecast By Material Type, 2016–2025
11.3. Market Value Forecast By Selection Technique, 2016–2025
11.4. Market Value Forecast By Application, 2016-2025
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Material Type
11.5.3. By Selection Technique
11.5.4. By Application
11.6. Key Trends
Chapter 12. Latin America Aptamer Market Analysis and Forecast
12.1. Market Value Forecast By Country, 2017–2025
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Rest of LATAM
12.2. Market Value Forecast By Material Type, 2016–2025
12.3. Market Value Forecast By Selection Technique, 2016–2025
12.4. Market Value Forecast By Application, 2016-2025
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Material Type
12.5.3. By Selection Technique
12.5.4. By Application
12.6. Key Trends
Chapter 13. Rest of World Aptamer Market Analysis and Forecast
13.1. Market Value Forecast By Material Type, 2016–2025
13.2. Market Value Forecast By Selection Technique, 2016–2025
13.3. Market Value Forecast By Application, 2016-2025
13.4. Market Attractiveness Analysis
13.4.1. By Material Type
13.4.2. By Selection Technique
13.4.3. By Application
13.5. Key Trends
Chapter 14. Competition Landscape
14.1. Competition Matrix
14.2. Company Profiles
14.2.1. AM Biotech. (HQ, Business Segments, Employee Strength)
14.2.1.1. Company Details
14.2.1.2. Company Description
14.2.1.3. Business Overview
14.2.1.4. SWOT Analysis
14.2.1.5. Financial Analysis
14.2.1.6. Strategic Overview
14.2.2. Aptagen, LLC. (HQ, Business Segments, Employee Strength)
14.2.2.1. Company Details
14.2.2.2. Company Description
14.2.2.3. Business Overview
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. Aptamer Group (HQ, Business Segments, Employee Strength)
14.2.3.1. Company Details
14.2.3.2. Company Description
14.2.3.3. Business Overview
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Aptamer Science, Inc. (HQ, Business Segments, Employee Strength)
14.2.4.1. Company Details
14.2.4.2. Company Description
14.2.4.3. Business Overview
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. Pfizer Inc. (HQ, Business Segments, Employee Strength)
14.2.5.1. Company Details
14.2.5.2. Company Description
14.2.5.3. Business Overview
14.2.5.4. SWOT Analysis
14.2.5.5. Financial Analysis
14.2.5.6. Strategic Overview
14.2.6. Base Pair Biotechnologies (HQ, Business Segments, Employee Strength)
14.2.6.1. Company Details
14.2.6.2. Company Description
14.2.6.3. Business Overview
14.2.6.4. SWOT Analysis
14.2.6.5. Financial Analysis
14.2.6.6. Strategic Overview
14.2.7. CD Genomics (HQ, Business Segments, Employee Strength)
14.2.7.1. Company Details
14.2.7.2. Company Description
14.2.7.3. Business Overview
14.2.7.4. SWOT Analysis
14.2.7.5. Financial Analysis
14.2.7.6. Strategic Overview
14.2.8. NeoVentures Biotechnology Inc. (HQ, Business Segments, Employee Strength)
14.2.8.1. Company Details
14.2.8.2. Company Description
14.2.8.3. Business Overview
14.2.8.4. SWOT Analysis
14.2.8.5. Financial Analysis
14.2.8.6. Strategic Overview
14.2.9. NAXXON Pharma (HQ, Business Segments, Employee Strength)
14.2.9.1. Company Details
14.2.9.2. Company Description
14.2.9.3. Business Overview
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. Aptus Biotech (HQ, Business Segments, Employee Strength)
14.2.10.1. Company Details
14.2.10.2. Company Description
14.2.10.3. Business Overview
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview
14.2.11. TriLink Bio Technologies, LLC (HQ, Business Segments, Employee Strength)
14.2.11.1. Company Details
14.2.11.2. Company Description
14.2.11.3. Business Overview
14.2.11.4. SWOT Analysis
14.2.11.5. Strategic Overview
List of Figures
Figure 01: Global Aptamer Market Snapshot
Figure 02: Global Aptamer Market Size (US$ Mn) Forecast, 2015–2025
Figure 03: Global Aptamer Y-o-Y Growth Rate (%), 2016–2025
Figure 04: Global Aptamer Market Value Share, by Region (2016
Figure 05: Global Aptamer Market Value Share, by Material Type (2016)
Figure 06: Global Addiction Treatment Market Value Share, by Application (2016)
Figure 07: Global Aptamer Market Value Share, by Selection Technique (2016)
Figure 08: Global Aptamer Market, by Material Type
Figure 09: Global Aptamer Market Value Share Analysis, by Material Type, 2016 and 2025
Figure 10: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nucleic acid (DNA or RNA) Aptamer 2015–2025
Figure 11: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Peptide Aptamer 2015–2025
Figure 12: Global Aptamer Market Attractiveness Analysis, by Material Type
Figure 13: Global Aptamer Market, by Selection Technique
Figure 14: Global Aptamer Market Value Share Analysis, by Selection Technique, 2016 and 2025
Figure 15: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by SELEX 2015–2025
Figure 16: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others 2015–2025
Figure 17: Global Aptamer Market Attractiveness Analysis, by Selection Technique
Figure 18: Global Aptamer Market, by Application
Figure 19: Global Aptamer Market, by Application
Figure 20: Global Aptamer Market Value Share Analysis, by Application, 2016 and 2025
Figure 21: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research 2015–2025
Figure 22: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics 2015–2025
Figure 23: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Therapeutics 2015–2025
Figure 24: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others 2015–2025
Figure 25: Global Aptamer Market Attractiveness Analysis, by Application
Figure 26: Global Radiation Dose Management Market
Figure 27: Global Aptamer Market Value Share Analysis, by Region, 2016 and 2025
Figure 28: Global Aptamer Market Attractiveness Analysis, by Region
Figure 29: North America Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 30: North America Aptamer Market Value Share, by Country, 2016 and 2025
Figure 31: North America Aptamer Market Attractiveness, by Country, 2016–2025
Figure 32: North America Aptamer Market Value Share, by Material Type, 2016 and 2025
Figure 33: North America Aptamer Market Attractiveness, by Material Type, 2016–2025
Figure 34: North America Aptamer Market Value Share, Selection Technique, 2016 and 2025
Figure 35: North America Aptamer Market Attractiveness Analysis, Selection Technique, 2016–2025
Figure 36: North America Aptamer Market Value Share, by Application, 2016 and 2025
Figure 37: North America Aptamer Market Attractiveness Analysis, by Application, 2016–2025
Figure 38: Europe Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 39: Europe Aptamer Market Value Share, by Country, 2016 and 2025
Figure 40: Europe Aptamer Market Attractiveness, by Country, 2016–2025
Figure 41: Europe Aptamer Market Value Share, by Material Type, 2016 and 2025
Figure 42: Europe Addiction Treatment Market Attractiveness, by Material Type, 2016–2025
Figure 43: Europe Aptamer Market Value Share, by Selection Technique, 2016 and 2025
Figure 44: Europe Aptamer Market Attractiveness Analysis, by Selection Technique, 2016–2025
Figure 45: Europe Aptamer Market Value Share, by Application, 2016 and 2025
Figure 46: Europe Aptamer Market Attractiveness Analysis, by Application, 2016–2025
Figure 47: Asia Pacific Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 48: Asia Pacific Aptamer Market Value Share, by Country, 2016 and 2025
Figure 49: Asia Pacific Aptamer Market Attractiveness, by Country, 20176–2025
Figure 50: Asia Pacific Aptamer Market Value Share, by Material Type, 2016 and 2025
Figure 51: Asia Pacific Aptamer Market Attractiveness, by Material Type, 2016–2025
Figure 52: Asia Pacific Aptamer Market Value Share, Selection Technique, 2016 and 2025
Figure 53: Asia Pacific Aptamer Market Attractiveness Analysis, Selection Technique, 2016–2025
Figure 54: Asia Pacific Aptamer Market Value Share, by Application, 2016 and 2025
Figure 55: Asia Pacific Aptamer Market Attractiveness Analysis, by Application, 2016–2025
Figure 56: Latin America Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 57: Latin America Aptamer Market Value Share, by Country, 2016 and 2025
Figure 58: Latin America Aptamer Market Attractiveness, by Country, 2016–2025
Figure 59: Latin America Aptamer Market Value Share, by Material Type, 2016 and 2025
Figure 60: Latin America Aptamer Market Attractiveness, by Material Type, 2016–2025
Figure 61: Latin America Aptamer Market Value Share, Selection Technique, 2016 and 2025
Figure 62: Latin America Aptamer Market Attractiveness Analysis, Selection Technique, 2016–2025
Figure 63: Latin America Aptamer Market Value Share, by Application, 2016 and 2025
Figure 64: Latin America Aptamer Market Attractiveness Analysis, by Application, 2016–2025
Figure 65: Rest of World Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 66: Rest of World Aptamer Market Value Share, by Material Type, 2016 and 2025
Figure 67: Rest of World Aptamer Market Attractiveness, by Material Type, 2016–2025
Figure 68: Rest of World Aptamer Market Value Share, Selection Technique, 2016 and 2025
Figure 69: Rest of World Aptamer Market Attractiveness Analysis, Selection Technique, 2016–2025
Figure 70: Rest of World Aptamer Market Value Share, by Application, 2016 and 2025
Figure 71: Rest of World Aptamer Market Attractiveness Analysis, by Application, 2016–2025
Figure 72: Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 73: Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 74: Pfizer, Inc. Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes